Lifestyle Counseling in Primary Care Setting Dramatically Reduces Time to Reach Treatment Goals for People with Diabetes

 

Boston, MA (January 24, 2012) Lifestyle counseling, practiced as part of routine care for people with diabetes, helps people more quickly lower blood glucose, blood pressure and cholesterol levels and keep them under control, according to a large, long-term study published in the February issue of Diabetes Care.

 

Researchers at Brigham and Women’s Hospital (BWH) conducted a retrospective cohort study of more than 30,000 people with diabetes who received diet, exercise and weight-loss counseling in a primary care setting over the course of at least two years (with an average follow-up time of almost seven years) and who had elevated blood glucose, blood pressure or cholesterol.

 

They found that the use of counseling reduced the time it took for patients to lower blood glucose, blood pressure and cholesterol levels. Previous studies have documented the success of counseling in a clinical trial setting, but until now many have questioned whether it would be as effective when conducted as part of ongoing treatment in a primary care setting, where fewer resources are available and patients may be less motivated.

 

"This study shows that persistent lifestyle counseling can and should be a critical piece of any routine diabetes treatment plan," said senior author Alexander Turchin, MD, MS, director of informatics research at the BWH Division of Endocrinology. "Clearly it gets people to goals faster than when they are not given continued encouragement and information on how to increase physical activity levels, eat properly and reduce lipids. Primary care providers should take these findings to heart."

 

The study found that the more frequently patients received counseling, the faster they reached their treatment goals, with those who received counseling at least once a month achieving the best results. Those who received face-to-face counseling once a month or more took an average of 3.9 weeks to reach their target goals for A1C, blood pressure and cholesterol, as compared to 13.5 months for those who received counseling only once every one to six months.

 

Because counseling can be time intensive, researchers recommend that working with providers such as nurse practitioners, physician assistants or dietitians, as well as providing support in group settings, may be more cost-effective ways of providing this necessary support.

 

This research was supported by the Agency for Healthcare Research and Quality, National Library of Medicine, and Diabetes Action Research and Education Foundation.

 

 


This press release was provided by the American Diabetes Association, 24.01.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung